Stocks TelegraphStocks Telegraph
Stock Ideas

SCNI Company Profile and Key Details

NASDAQ : SCNI

Scinai Immunotherapeutics Ltd.

$3.57
0.0536+1.52%
At Close 4:00 PM

SCNI Stock Price Chart

Stock Price Today

Scinai Immunotherapeutics Ltd. (SCNI) stock surged +1.52%, trading at $3.57 on NASDAQ, up from the previous close of $3.52. The stock opened at $3.57, fluctuating between $3.55 and $3.73 in the recent session.

Stock Snapshot

3.52
Prev. Close
3.57
Open
3.05M
Market Cap
853K
Number of Shares
3.55
Day Low
3.7282
Day High
1.49
P/E Ratio
97.75%
Free Float in %
2.4
EPS (TTM)
N/A
Book Value
N/A
Cash Flow per Share
6.04K
Volume

Stock Price History Chart

DateOpenHighLowCloseVolume
Jan 22, 20253.453.733.453.577.07K
Jan 21, 20253.483.683.463.5619.48K
Jan 17, 20253.593.603.503.514.84K
Jan 16, 20253.473.603.453.575.44K
Jan 15, 20253.443.483.423.443.83K
Jan 14, 20253.523.533.423.443.3K
Jan 13, 20253.463.653.403.427.4K
Jan 10, 20253.803.803.523.534.5K
Jan 08, 20253.603.603.373.4610.5K
Jan 07, 20253.813.823.623.6512.12K
Jan 06, 20253.703.933.633.7720.95K
Jan 03, 20253.483.603.323.6010.44K
Jan 02, 20253.383.543.323.4415.9K
Dec 31, 20243.283.353.273.3511.2K
Dec 30, 20243.303.383.273.3612K
Dec 27, 20243.443.503.323.4010.63K
Dec 26, 20243.303.543.303.442.53K
Dec 24, 20243.353.353.303.356.2K
Dec 23, 20243.323.453.323.352.06K
Dec 20, 20243.353.503.353.405.55K

Contact Details

Jerusalem,

Israel

Website: https://www.scinai.comContact: 972 893 02529

About Company

Scinai Immunotherapeutics Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases, and other illnesses in Israel. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is headquartered in Jerusalem, Israel.

Company Information

Employees31
Beta2.46
Sales or RevenueN/A
5Y Sales Change%0%
Fiscal Year EndsN/A
SectorHealthcare
IndustryBiotechnology

Frequently Asked Questions

What is the current Scinai Immunotherapeutics Ltd. (SCNI) stock price?

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) stock price is $3.57 in the last trading session. During the trading session, SCNI stock reached the peak price of $3.73 while $3.55 was the lowest point it dropped to. The percentage change in SCNI stock occurred in the recent session was 1.52% while the dollar amount for the price change in SCNI stock was $0.05.

SCNI's industry and sector of operation?

The NASDAQ listed SCNI is part of Biotechnology industry that operates in the broader Healthcare sector. Scinai Immunotherapeutics Ltd. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of SCNI?

No Data

How SCNI did perform over past 52-week?

SCNI's closing price is 60.25% higher than its 52-week low of $2.23 where as its distance from 52-week high of $8.92 is -59.94%.

How many employees does SCNI have?

Number of SCNI employees currently stands at 31.

Link for SCNI official website?

Official Website of SCNI is: https://www.scinai.com

How do I contact SCNI?

SCNI could be contacted at phone 972 893 02529 and can also be accessed through its website. SCNI operates from Jerusalem BioPark Building, Jerusalem, , Israel.

How many shares of SCNI are traded daily?

SCNI stock volume for the day was 6.04K shares. The average number of SCNI shares traded daily for last 3 months was 10.65K.

What is the market cap of SCNI currently?

The market value of SCNI currently stands at $3.05M with its latest stock price at $3.57 and 853K of its shares outstanding.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph